Article

Extracorporeal Photochemotherapy: A Case Report and Update

Author and Disclosure Information

Extracorporeal photochemotherapy (ECP) was developed at Columbia Presbyterian Medical Center in the early 1980s for the treatment of cutaneous T-cell lymphoma (CTCL). ECP is now used primarily in the treatment of that disease at more than 100 centers worldwide. It also has been shown to be potentially effective in treating several autoimmune diseases. Most recently, it has been used in reversing solid-organ transplant rejection and graft-versus-host disease following bone-marrow transplantation. In this article, we present the case of one of the first patients treated with ECP and give an update on the current status of this therapy.


 

Recommended Reading

On the Front Line [editorial]
MDedge Dermatology
What Is Your Diagnosis? Alopecia Areata of the Eyelashes
MDedge Dermatology
What's Eating You: Centruroides exilicauda
MDedge Dermatology
Maffucci Syndrome: A Case Report
MDedge Dermatology
Eyelid Pilomatricomas in Young Adults: A Report of 8 Cases
MDedge Dermatology
Cutaneous Anthrax: A Concise Review
MDedge Dermatology
An Eruption Secondary to Intravenous Immunoglobulin Therapy
MDedge Dermatology
Hereditary Pincer Nail
MDedge Dermatology
Periungual Myxoid Neurofibroma
MDedge Dermatology
Perianal Ulcerations From Topical Steroid Use
MDedge Dermatology